Group 1 - The "Phoenix Bay Area Finance Forum 2025" was held in Guangzhou on September 23-24, focusing on the theme "New Pattern, New Path" and gathering global political, business, and academic elites to explore development opportunities [1] Group 2 - Wang Yonghui, Chairman of Guangzhou Xiangxue Pharmaceutical Co., Ltd., emphasized the spirit and aspirations of Chinese enterprises in the globalization process during his keynote speech [3] - He highlighted the explosive growth of Chinese biomedicine going abroad, with this year's overseas scale exceeding $80 billion, transitioning from simple product exports to intellectual property exports [3] - Wang pointed out that Traditional Chinese Medicine (TCM) represents unique Chinese cultural and medical resources, and it is currently facing a historic opportunity for internationalization [3] - He illustrated TCM's global influence, stating that "TCM is medicine for humanity, belonging to China and the world, as it is a shared wealth of all mankind" [3] - Despite its potential, he acknowledged that TCM's actual application in medicine remains limited, indicating that true acceptance and integration into global healthcare is still a distant goal [3]
香雪制药董事长王永辉:中医是为人而设的医学,它属于中国,更属于世界